Statements (71)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:KRAS
|
| gptkbp:can_metastasize_to |
gptkb:skincare_product
liver bones adrenal glands |
| gptkbp:caused_by |
respiratory symptoms
cancer deaths |
| gptkbp:has_style |
acinar adenocarcinoma
invasive adenocarcinoma lepidic adenocarcinoma papillary adenocarcinoma solid adenocarcinoma |
| https://www.w3.org/2000/01/rdf-schema#label |
lung adenocarcinoma
|
| gptkbp:is_associated_with |
gptkb:KRAS_mutations
genetic mutations smoking survival rates tumor microenvironment EGFR mutations ALK rearrangements |
| gptkbp:is_characterized_by |
inflammatory response
poor prognosis high mitotic activity pleomorphic cells cellular atypia glandular structures mucin production |
| gptkbp:is_influenced_by |
gptkb:satellite
environmental factors lifestyle choices socioeconomic status dietary factors occupational hazards |
| gptkbp:is_monitored_by |
CT scans
PET scans recurrence |
| gptkbp:is_often_used_in |
gptkb:philosopher
non-smokers |
| gptkbp:is_part_of |
oncology research
cancer education programs cancer registries lung cancer awareness campaigns lung cancer spectrum |
| gptkbp:is_recognized_by |
gptkb:hospital
gptkb:World_Health_Organization a public health issue |
| gptkbp:is_studied_in |
clinical trials
treatment advancements |
| gptkbp:risk_factor |
family history
exposure to asbestos exposure to radon |
| gptkbp:scientific_classification |
gptkb:healthcare_organization
histological features |
| gptkbp:social_responsibility |
biopsy
imaging tests immunohistochemistry |
| gptkbp:symptoms |
weight loss
cough chest pain shortness of breath |
| gptkbp:treatment |
gptkb:hospital
gptkb:vaccine gptkb:municipality palliative care radiation therapy chemotherapy targeted therapy staging specialized cancer centers |